Within the glucose monitoring market, continuous glucose monitoring (CGM) is a way for patients to continually measure their glucose levels in different settings. Four companies compete to gain a dominant stance within the U.S. continuous glucose monitoring market. The ranking of each company along with their product offerings and associated segments are discussed within this
Researchers at UCSF have developed a method to help detect diabetes using a smartphone. They have developed a deep-learning technology that can be combined with a mobile app to offer a low-cost method of detecting diabetes. Instant Heart Rate Measurement The Azumio Instant Heart Rate app was recently used as part of the Health eHeart
The most recent integrated continuous glucose monitor (iCGM) from Abbott, the Freestyle Libre 2, has been granted FDA approval for sale in the U.S. to adults and children over the age of four with diabetes. The Freestyle Libre 2 has several innovative features. It is the only iCGM system that measures glucose levels each minute,
Dexcom has announced that its G6 continuous glucose monitoring (CGM) system has won the CE Mark for use during pregnancy and will be available in the United Kingdom as soon as Spring 2020. During pregnancy, hormones that help the baby grow block the mother’s natural production of insulin and can cause insulin resistance. If insulin
Medtronic has recalled the MiniMed 600 Series Insulin Pumps due to missing or broken retainer rings resulting in incorrect insulin dosages. The MiniMed Insulin Pumps are designed to administer proper doses of insulin when the user’s blood sugar levels dip. In the defective devices, the retainer ring, which is supposed to lock the insulin cartridge
A clinical trial, funded by the National Institutes of Diabetes and Digestive and Kidney Diseases (NIDDK) revealed closed-loop artificial pancreas were better at controlling patients’ blood glucose levels than existing treatments. The artificial pancreas allows for ‘closed-loop’ control which tracks blood glucose levels constantly with a continuous glucose monitor (CGM) and automatically delivers insulin via
Register to receive a free Diabetes Market Analysis, Size, and Trends Report synopsis and brochure. Back in 2017, the FDA approved Fiasp, a rapid-acting insulin, for use by IV infusion under supervision by a healthcare professional or by subcutaneous multiple daily injection (MDI) in adults with diabetes. It is currently the only insulin injection that
Register to receive a free U.S. Market Report Suite for Diabetes Devices report synopsis and brochure UC Davis Health scientists and physicians have discovered a cellular connection between diabetes and blood vessel narrowing that increases risks of serious health conditions such as heart disease and stroke. Previously, this same team of researchers found that high blood glucose activates
Register to receive a free U.S. Market Report Suite for Diabetes Devices report synopsis and brochure On May 21 2019, LifeScan announced a partnership with Sanvita Medical to move into the continuous glucose monitoring (CGM) market this week, which is poised to become the standard of care for the vast majority of people with diabetes who
Register to receive a free US Market Report Suite for Diabetes Devices report synopsis and brochure Insulin Statistics Insulin is a hormone that causes glucose uptake from the blood through the cells of the liver, muscle, and fat tissue to be stored as glycogen in the liver and muscle. Despite many key differences between type 1 diabetes
